by 
Immunohistochemistry: A Powerful Diagnostic Tool
Immunohistochemistry (IHC) is a technique that uses antibodies to detect antigens in cells of a tissue section. Over the past few decades, IHC has revolutionized the field of pathology and become an invaluable diagnostic tool. In this article, we will explore how IHC works, its applications in disease diagnosis and research, and new developments that are further enhancing its capabilities.
How IHC Works
At its core, IHC relies on the properties of antibodies and antigens. Antibodies are Y-shaped proteins produced by our immune system to identify and target foreign objects called antigens. In IHC, specific antibodies are used to detect antigens like proteins in tissue samples. The basic steps involve:
1. Fixation and Sectioning: Tissue samples from biopsies or surgical specimens are fixed, processed and cut into thin sections. This preserves cell structures and antigens within the tissue.
2. Antigen Retrieval: Sometimes heat treatment or chemical treatment is used to uncover masked antigens within fixed tissues.
3. Blocking: Non-specific antibody binding sites are blocked to reduce background staining.
4. Primary Antibody: The section is incubated with a primary antibody specific to the antigen of interest. The primary antibody binds to any antigens present.
5. Labeling: The bound primary antibodies are then detected using a secondary antibody conjugated to an enzyme or fluorophore, acting as a label.
6. Visualization: Substrates are added that react with the label, causing a color change that can be seen under a microscope. This reveals the location of the antigen within the tissue.
Diagnosing Disease with IHC
IHC has had an enormous impact on disease diagnosis. It allows pathologists to swiftly determine tumor types and subtypes based on biomarker expression profiles. Some examples include:
– Breast cancer: IHC tests for estrogen receptor, progesterone receptor and HER2 status guide treatment decisions.
– Lymphoma: Antibodies against CD20, CD3 and other markers help distinguish aggressive lymphomas from more indolent types.
– Liver cancer: Alpha-fetoprotein and glypican-3 help diagnose hepatocellular carcinoma over other liver tumors.
– Prostate cancer: P504S and prostate specific antigen indicate prostatic origin in metastatic tumors.
– Melanoma: S100, HMB45 and melan-A confirm difficult-to-diagnose lesions are melanocytic in origin.
IHC also aids in detecting infection causing pathogens. For instance, tests for Cryptococcal antigen detect fungal meningitis, helping guide antifungal therapy. With a rapidly growing antibody toolkit, IHC continues finding new diagnostic applications.
Using IHC for Prognosis and Research
Beyond diagnosis, IHC provides valuable prognostic information. For example, hormone receptor status in breast cancer determines treatment response and tumor recurrence risk. Proliferation markers like Ki-67 indicate aggressiveness.
Research applications of IHC are equally important. It allows investigating molecular pathways in health and disease. Spatial distribution of proteins within tissues can reveal new insights into disease processes. IHC also plays a crucial role in developing and validating targeted therapies by establishing biomarker expression patterns. With Multiplex-IHC techniques, expression of multiple antigens can be analyzed simultaneously within the same sample.
Future Directions in IHC
Digital pathology and artificial intelligence are areas primed to further advance IHC. Whole slide imaging coupled with deep learning allows computer-aided evaluation of IHC stains. This can improve diagnostic accuracy and reproducibility.
Other developing areas include novel pre-treatment methods to unmask difficult-to-detect antigens, highly sensitive silver-based amplification techniques, and multiplexing capabilities to study dozens of markers simultaneously. Portable microfluidic IHC devices also show promise for point-of-care clinical applications and resource-limited settings.
In conclusion, over the past few decades, IHC has grown from a specialized research tool into an indispensable modality for diagnostic surgical pathology. Through continued technological innovations, its diagnostic and research applications will only broaden further. IHC exemplifies how harnessing the properties of antibodies can significantly impact patient care and disease understanding.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
